Cargando…

Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats

Acute kidney injury (AKI) predicts poor prognosis in patients with acute myocardial infarction (MI) and diabetes mellitus (DM) is an independent risk factor of AKI. Recent clinical studies have shown the beneficial effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on cardiovascular and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuno, Atsushi, Kimura, Yukishige, Mizuno, Masashi, Oshima, Hiroto, Sato, Tatsuya, Moniwa, Norihito, Tanaka, Marenao, Yano, Toshiyuki, Tanno, Masaya, Miki, Takayuki, Miura, Tetsuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190820/ https://www.ncbi.nlm.nih.gov/pubmed/32350374 http://dx.doi.org/10.1038/s41598-020-64380-y

Ejemplares similares

Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts
por: Mizuno, Masashi, et al.
Publicado: (2018)

Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
por: Sato, Tatsuya, et al.
Publicado: (2018)

Reply to the comment of Hirota et al. on “Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes”
por: Sato, Tatsuya, et al.
Publicado: (2019)

Canagliflozin, a sodium–glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats
por: Kimura, Yukishige, et al.
Publicado: (2019)

Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus
por: Nakata, Kei, et al.
Publicado: (2017)

Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes
por: Muratsubaki, Shingo, et al.
Publicado: (2017)

Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats
por: Murase, Hiromichi, et al.
Publicado: (2015)

Does glycemic control reverse dispersion of ventricular repolarization in type 2 diabetes?
por: Miki, Takayuki, et al.
Publicado: (2014)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
por: Tanaka, Marenao, et al.
Publicado: (2017)

Accelerated Recovery of Mitochondrial Membrane Potential by GSK-3β Inactivation Affords Cardiomyocytes Protection from Oxidant-Induced Necrosis
por: Sunaga, Daisuke, et al.
Publicado: (2014)

Role of ER Stress in Ventricular Contractile Dysfunction in Type 2 Diabetes
por: Takada, Akifumi, et al.
Publicado: (2012)

Adenosine monophosphate deaminase in the endoplasmic reticulum–mitochondria interface promotes mitochondrial Ca(2+) overload in type 2 diabetes rat hearts
por: Osanami, Arata, et al.
Publicado: (2023)

Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts
por: Ogawa, Toshifumi, et al.
Publicado: (2023)

Increased LDL-cholesterol level is associated with deterioration of renal function in males
por: Osanami, Arata, et al.
Publicado: (2022)

Emerging beneficial roles of sirtuins in heart failure
por: Tanno, Masaya, et al.
Publicado: (2012)

Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy
por: Fujita, Yugo, et al.
Publicado: (2022)

Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor
por: Furuhashi, Masato, et al.
Publicado: (2016)

Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3β–Mediated Suppression of Mitochondrial Permeability Transition
por: Miki, Takayuki, et al.
Publicado: (2009)

Low urine pH predicts new onset of diabetes mellitus during a 10‐year period in men: BOREAS‐DM1 study
por: Higashiura, Yukimura, et al.
Publicado: (2020)

Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes
por: Sato, Tatsuya, et al.
Publicado: (2019)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria
por: Tanaka, Marenao, et al.
Publicado: (2020)

Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
por: Saito, Norie, et al.
Publicado: (2021)

High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

Differential regulation of hypoxanthine and xanthine by obesity in a general population
por: Furuhashi, Masato, et al.
Publicado: (2020)

Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects
por: Takahashi, Satoko, et al.
Publicado: (2021)

Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters
por: Furuhashi, Masato, et al.
Publicado: (2016)

Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary Artery
por: Numaguchi, Ryosuke, et al.
Publicado: (2019)

Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
por: Furuhashi, Masato, et al.
Publicado: (2017)

Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
por: Miki, Takayuki, et al.
Publicado: (2012)

The Use of Empagliflozin Post Myocardial Infarction
por: Ravendran, Kapilraj, et al.
Publicado: (2023)

Distinct risk factors of atrial fibrillation in patients with and without coronary artery disease: a cross-sectional analysis of the BOREAS-CAG Registry data
por: Murakami, Naoto, et al.
Publicado: (2017)

Empagliflozin in acute myocardial infarction: the EMMY trial( )
por: von Lewinski, Dirk, et al.
Publicado: (2022)

Empagliflozin induces the transcriptional program for nutrient homeostasis in skeletal muscle in normal mice
por: Kawakami, Ryo, et al.
Publicado: (2023)

Insulin Resistance is Associated with Longitudinal Changes of Cardiac Repolarization Heterogeneity in Apparently Healthy Subjects
por: Matsumoto, Tamaki, et al.
Publicado: (2019)

Diabetic cardiomyopathy: pathophysiology and clinical features
por: Miki, Takayuki, et al.
Publicado: (2012)

Reduction in GLP-1 secretory capacity may be a novel independent risk factor of coronary artery stenosis
por: Nagase, Chihiro, et al.
Publicado: (2021)

Usefulness of the Atherosclerosis Risk Score for Patients With Acute Infarction in the Lenticulostriate Artery Region
por: Nakamura, Hikaru, et al.
Publicado: (2022)

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5aqq9vv3qfrqkf8a4jkfl1bvvr